KaloCyte
Business Services · Maryland, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
670 W Baltimore St. Hsrf Iii Fl 8, Balti...Phone Number
(314) 286-2725Website
www.kalocyte.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About KaloCyte
KaloCyte, a preclinical-stage healthcare biotechnology company, was founded by a distinguished team of researchers in physiology, bioengineering, and trauma care. The company is poised to deliver ErythroMer, a freeze-dried, bio-inspired synthetic red blood cell, to market, with the expectation of starting human trials in two to three years. ErythroMer is envisioned for use when stored red blood cells are unavailable, undesirable or in short supply.Explore more
KaloCyte Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is KaloCyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on KaloCyte recently announced quarterly report
Click to see if KaloCyte had a recent Job posting/layoffs
Check out if KaloCyte is spiking on competitors!
KaloCyte, which may be a good buyer, showed buying intent in Masked Content Topic
Check if KaloCyte has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when KaloCyte launches new products
Funding: Get notified immidiatlly once KaloCyte has new funding data
Congratulate Masked Content for being promoted to Masked Content at KaloCyte
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to KaloCyte
Compare insights from companies similar to KaloCyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
KaloCyte is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
KaloCyte is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about KaloCyte.
KaloCyte financials insights
Gather financial insights about KaloCyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Angel/Seed
$300K
KaloCyte Tech Stack
A closer look at the technologies used by KaloCyte
See more technologies
Most Recent Scoops
Person-Based
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Person-Based
Person-Based
Funding
Project
Spending/Investment
KaloCyte News & Media
The UM BioPark is a beacon for early-stage technology ventures
The research park’s perfectly matched location and array of startup-supporting resources makes it an invaluable pillar for a growing number of life science startups — and the entire Maryland ecosystem.C-Suite Insights with Elaine Haynes, CEO of KaloCyte
Please tell us a little bit about yourself and your organization. I am CEO of KaloCyte, Inc., a pre-clinical biotech... Read More The post C-Suite Insights with Elaine Haynes, CEO of KaloCyte appeared first on citybiz.$ 7.38 Billion Growth in Global Artificial Blood Substitutes Market 2021-2025 | Featuring Major Vendors Including Hemoglobin Oxygen Therapeutics LLC and KaloCyte Inc. among others | Technavio
NEW YORK, March 11, 2021 /PRNewswire/ -- The global artificial blood substitutes market is expected to grow by USD 7.38 billion, progressing at a CAGR of 23% during 2021-2025. The market will witness strong growth in North America during the forecast period owing to the presence of...KaloCyte Relocates to Downtown Baltimore as Co-Founders Join University of Maryland Faculty
BALTIMORE, Sept. 23, 2019 /PRNewswire/ -- KaloCyte, a preclinical-stage healthcare biotechnology company developing a synthetic, bio-inspired red blood cell substitute for use in settings when stored red blood cells are not available, has joined Baltimore's growing biotech community as a...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding KaloCyte
Sign Up For FreeTo access detailed company insights
KaloCyte, a preclinical-stage healthcare biotechnology company, was founded by a distinguished team of researchers in physiology, bioengineering, and trauma care. The company is poised to deliver ErythroMer, a freeze-dried, bio-inspired synthetic red blood cell, to market, with the expectation of starting human trials in two to three years. Erythro... Read More
